Gentex GNTX Contingent consideration fair value adjustments

Contingent consideration fair value adjustments at other companies

MarshMRSH

$10M+300%

Rocket Lab USA, Inc.RKLB

$187K—

Comfort Systems USAFIX

$10.37M+176%

Tetra TechTTEK

$58K-97.0%

Tetra TechTTEK

$58K-97.0%

Boston ScientificBSX

-$30M-700%

Other financials

Income statement

See full

Revenue$675.4M+17.1%

Gross profit$228.6M+19.2%

Operating income$123.7M+9.4%

Net income$98.5M+3.8%

EPS (diluted)$0.46+9.5%

Balance sheet

See full

Cash & equivalents$164.8M-42.5%

Total debt$10.8M+123%

Total equity$2.5B+1.1%

Total assets$3.0B+7.7%

Cash flow

See full

Operating cash flow$137.1M-7.7%

CapEx$17.0M-53.6%

Free cash flow$120.0M+7.4%

Valuation

See full

Market cap$5.53B-11.1%

Enterprise value$5.37B-9.2%

P/E14.2×-1.7×

P/S2.1×-0.6×

Profitability

See full

Gross margin34.3%+1.2pp

Operating margin18.4%-0.9pp

Net margin14.8%-2.3pp

FCF margin17.7%+1.7pp

Returns & leverage

See full

Return on equity15.6%-0.5pp

Debt / equity0×0.0×

Current ratio2.7×-1.4×

Where this comes from

Reported directly by Gentex in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1.

The official record: Gentex’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gentex's contingent consideration fair value adjustments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Gentex's contingent consideration fair value adjustments?: Gentex (GNTX) reported contingent consideration fair value adjustments of $655.82K in Q4 2025.